Citation Tools

Download PDFPDF

Extended report
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study

Download to a citation manager

Cite this article as:
Braun J, Deodhar A, Inman RD, et al
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study